Satoko Nishimura

In vivo conversion of racemized β‐amyloid ([<scp>D</scp>‐Ser²⁶]Aβ1–40) to truncated and toxic fragments ([<scp>D</scp>‐Ser²⁶]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

Takekazu Kubo, Satoko Nishimura, Yoshihiro Kumagae et al. · Journal of Neuroscience Research · 2002 · 245 citations

Life Sciences, Biochemistry, Neuroscience +17

Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets

Joanna L. Kaplan, Joshua A. Stern, Andrea J. Fascetti et al. · PLoS ONE · 2018 · 100 citations · Full text

Agriculture, Animal Sciences, Nutrition +17

A novel<i>β</i>‐sheet breaker, RS‐0406, reverses amyloid<i>β</i>‐induced cytotoxicity and impairment of long‐term potentiation<i>in vitro</i>

Yasuhiro Nakagami, Satoko Nishimura, Takako Murasugi et al. · British Journal of Pharmacology · 2002 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of Physiologically Active Substances as Novel Ligands for MRGPRD

Makiko Uno, Satoko Nishimura, Keisuke Fukuchi et al. · Journal of Biomedicine and Biotechnology · 2012 · 60 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Short latency SEPs in infants and children: Developmental changes and maturational index of SEPs

Yutaka Tomita, Satoko Nishimura, Tomoko Tanaka · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · 1986 · 40 citations

Life Sciences, Neuroscience, Pediatrics +9